MAO (monoamine oxidase) inhibitors are a category of antidepressants that, when employed in combination with copyright amphetamines like 3-MMC or copyright, may perhaps bring about a likely lethal issue generally known as “serotonin syndrome.”Of the presumably 9 monointoxication deaths involving only 3-MMC which have transpired, two monointoxic